{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:31:48Z","timestamp":1769931108472,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.7759\/cureus.102728","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T19:10:03Z","timestamp":1769886603000},"source":"Crossref","is-referenced-by-count":0,"title":["Missed Autoimmune Diabetes: Latent Autoimmune Diabetes in Adults in the Setting of Autoimmune Clustering"],"prefix":"10.7759","author":[{"given":"Saraswathi","family":"Saiprasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayana","family":"Swamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1960-7","article-title":"Latent autoimmune diabetes in adults (LADA) should be less latent","volume":"48","author":"Fourlanos S","year":"2005","unstructured":"Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia. 2005, 48:2206-12. 10.1007\/s00125-005-1960-7","journal-title":"Diabetologia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1120","article-title":"Latent autoimmune diabetes in adults","volume":"94","author":"Naik RG","year":"2009","unstructured":"Naik RG, Brooks-Worrell BM, Palmer JP. Latent autoimmune diabetes in adults. J Clin Endocrinol Metab. 2009, 94:4635-44. 10.1210\/jc.2009-1120","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0931","article-title":"Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7","volume":"36","author":"Hawa MI","year":"2013","unstructured":"Hawa MI, Kolb H, Schloot N, et al.. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care. 2013, 36:908-13. 10.2337\/dc12-0931","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04501.x","article-title":"Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation","volume":"167","author":"Brooks-Worrell B","year":"2012","unstructured":"Brooks-Worrell B, Palmer JP. Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation. Clin Exp Immunol. 2012, 167:40-6. 10.1111\/j.1365-2249.2011.04501.x","journal-title":"Clin Exp Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1696","article-title":"High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes","volume":"30","author":"Buzzetti R","year":"2007","unstructured":"Buzzetti R, Di Pietro S, Giaccari A, et al.. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care. 2007, 30:932-8. 10.2337\/dc06-1696","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2305","article-title":"Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: non insulin requiring autoimmune diabetes (NIRAD) 4","volume":"33","author":"Lampasona V","year":"2010","unstructured":"Lampasona V, Petrone A, Tiberti C, et al.. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: non insulin requiring autoimmune diabetes (NIRAD) 4. Diabetes Care. 2010, 33:104-8. 10.2337\/dc08-2305","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti R","year":"2020","unstructured":"Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD. Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes. 2020, 69:2037-47. 10.2337\/dbi20-0017","journal-title":"Diabetes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90838","article-title":"From glycemia to grip: a comprehensive review of musculoskeletal complications in diabetic patients","volume":"17","author":"Hussain S","year":"2025","unstructured":"Hussain S, Irfan M, Khan M, et al.. From glycemia to grip: a comprehensive review of musculoskeletal complications in diabetic patients. Cureus. 2025, 17:e90838. 10.7759\/cureus.90838","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/452322-missed-autoimmune-diabetes-latent-autoimmune-diabetes-in-adults-in-the-setting-of-autoimmune-clustering","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T19:10:04Z","timestamp":1769886604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/452322-missed-autoimmune-diabetes-latent-autoimmune-diabetes-in-adults-in-the-setting-of-autoimmune-clustering"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.102728","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,31]]}}}